Journal of Cognitive Psychotherapy, published by SPRINGER PUBLISHING CO, is a premier academic platform that has been advancing the field of cognitive psychology and psychotherapy since its inception in 1987. With an ISSN of 0889-8391 and an E-ISSN of 1938-887X, this journal is committed to disseminating high-quality research and innovative practices within its scope, which encompasses clinical psychology, experimental and cognitive psychology, as well as psychiatry and mental health. Ranked in the third quartile (Q3) in the 2023 category quartiles for these fields, it serves as a vital resource for researchers, healthcare professionals, and students alike, providing insights that contribute to theory, practice, and future research directions. Although currently not an Open Access journal, Journal of Cognitive Psychotherapy remains dedicated to fostering collaboration and growth within the psychological community, offering essential findings that support clinical practices and enhance therapeutic outcomes.

Journal of Pharmacological Sciences is a leading peer-reviewed academic journal dedicated to the field of pharmacology, published by the Japanese Pharmacological Society. Since its inception, this journal has offered an essential platform for the dissemination of high-quality research, contributing significantly to advancements in molecular medicine and pharmacology. With an impact factor that places it in the prestigious Q2 quartile for both categories, the journal has established itself as a credible source of innovative findings and methodologies since its transition to Open Access in 2015. This accessibility enables a broader audience, including researchers, healthcare professionals, and students, to engage with valuable insights and discussions pertinent to drug development, pharmacodynamics, and therapeutic strategies. Based in Kyoto, Japan, the journal serves as a vital resource for the global pharmacological community, encouraging collaboration and research that leads to improved health outcomes. For more information, submissions, and access to the latest research, visit the journal’s website.

The European Journal of Psychotherapy & Counselling, published by Routledge Journals, Taylor & Francis Ltd, is a leading platform dedicated to advancing the fields of psychotherapy and counseling in Europe and beyond. With an ISSN of 1364-2537 and E-ISSN 1469-5901, this journal aims to foster interdisciplinary dialogue among researchers, practitioners, and educators by presenting innovative research, critical reviews, and practical insights. Despite its current ranking in the Q4 quartile for both Clinical Psychology and Psychiatry and Mental Health, the journal's commitment to improving therapeutic practices and understanding patient experiences underscores its importance in the mental health landscape. Addressing a wide range of topics from evidence-based therapies to emerging therapeutic modalities, the journal aspires to enhance knowledge and promote effective counseling practices. While it does not offer Open Access options, the European Journal of Psychotherapy & Counselling continues to serve as a vital resource for those invested in the enhancement of psychological well-being.

ANNALS OF PHARMACOTHERAPY, published by SAGE PUBLICATIONS INC, is a leading journal in the realm of pharmacology and therapeutic science, dedicated to advancing research, clinical practice, and education in the field of medicine. With a solid history dating back to its first publication in 1981, this journal offers a platform for high-quality research articles that explore the latest innovations and methodologies in pharmacotherapy. Although it operates under a subscription-based model, the journal maintains a robust academic reputation, reflected in its Scopus ranking in the 68th percentile within the category of Medicine - Pharmacology (Rank #85/272). The impact factor is continually evolving, as is the scope, which encompasses a diverse range of topics from clinical trials to the therapeutic applications of newly-developed drugs. Researchers, professionals, and students alike will find valuable insights and cutting-edge research in the ANNALS OF PHARMACOTHERAPY, making it an essential resource for anyone engaged in the field of pharmacology.

Journal of Pharmacology & Pharmacotherapeutics is a vital academic resource published by SAGE Publications Inc., focusing on the diverse and evolving fields of pharmacology and pharmacotherapy. With an ISSN of 0976-500X and E-ISSN 0976-5018, this journal serves as a platform for rigorous research and innovative insights from 2010 to 2024, reflecting the latest advancements and challenges within the pharmacological landscape. Despite being placed in the Q4 quartile for both general pharmacology and medical pharmacology in 2023, it continues to be an essential resource for researchers, professionals, and students striving to understand the complexities of drug action, therapy optimization, and pharmaceutical sciences. The journal underscores the importance of disseminating critical findings to stimulate further research and collaborative dialogue. Although currently not open access, it can be accessed through leading academic databases, positioning itself as a significant entity in the medical and pharmacological research community.

CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, published by WILEY, is a premier journal that serves as a vital resource for researchers, professionals, and students in the fields of pharmacology and physiology. With ISSN 0305-1870 and E-ISSN 1440-1681, this journal has established itself as a significant contributor to scientific dialogue since its inception in 1974. Currently spanning until 2024, it consistently publishes cutting-edge research addressing both experimental and clinical advancements in pharmacology and physiology. Recognized for its quality, it holds a Q2 ranking in the 2023 Pharmacology category and notable Q3 rankings in both Physiology and Medical Physiology. The journal's coverage of topical issues not only ensures a robust platform for innovative findings but also fosters collaborations across disciplines. Although not an Open Access journal, its curated content is invaluable for advancing knowledge, as evidenced by its solid Scopus rankings, which place it within the top percentiles of its field. Engaging with this journal means staying at the forefront of research that shapes clinical practices and experimental methodologies.

PERSPECTIVES IN PSYCHIATRIC CARE, published by WILEY, is an esteemed journal that serves as a pivotal resource for researchers, professionals, and students in the realms of psychiatry and mental health. With a history dating back to 1963 and ongoing contributions through 2024, this journal showcases a rich convergence of innovative research and clinical practice. The journal is recognized in prestigious databases with a Scopus rank placing it at #10 out of 45 in the field of Nursing - Psychiatric Mental Health, highlighting its significant influence and relevance. As a Q2 ranked journal in both the Medicine (miscellaneous) and Psychiatry and Mental Health categories, it offers a platform for interdisciplinary collaboration and exploration of contemporary issues in mental health care. Although it does not offer open access, PERSPECTIVES IN PSYCHIATRIC CARE provides a comprehensive collection of scholarly articles that advance the field and support best practices in psychiatric care, making it an essential publication for anyone committed to enhancing mental health outcomes.

JOURNAL OF PSYCHOTHERAPY INTEGRATION, an esteemed publication of the Educational Publishing Foundation—American Psychological Association, serves as a vital resource for researchers and practitioners in the fields of clinical psychology and psychiatry. With an ISSN of 1053-0479 and an E-ISSN of 1573-3696, this journal has become a cornerstone in advancing knowledge on the integration of psychotherapeutic techniques, offering insights into the evolving practices from 1996 to 2024. The journal holds a respectable status in academic circles, categorized in the Q2 quartile for both Clinical Psychology and Psychiatry and Mental Health, and achieving impressive Scopus rankings that position it within the top percentiles of its fields. Despite the absence of Open Access, readers can benefit from its comprehensive articles that blend theoretical frameworks with empirical research, aimed at enhancing therapeutic outcomes. As an important forum for scholarly dialogue, the JOURNAL OF PSYCHOTHERAPY INTEGRATION underscores the significance of integrative approaches in mental health treatment, making it an essential read for professionals, researchers, and students committed to the advancement of psychotherapy practices.

ZEITSCHRIFT FUR KLINISCHE PSYCHOLOGIE UND PSYCHOTHERAPIE is a distinguished academic journal published by HOGREFE VERLAG, renowned for its commitment to advancing the fields of clinical psychology and psychotherapy. With its inception dating back to 1974, this journal has been a vital platform for disseminating cutting-edge research, innovative therapeutic techniques, and critical reviews in the realm of clinical psychology. The journal currently holds an impact factor that reflects its significance in the academic community, with a category rank of Q3 in Clinical Psychology according to 2023 quartiles. Although it operates without open access, ZEITSCHRIFT FUR KLINISCHE PSYCHOLOGIE UND PSYCHOTHERAPIE provides invaluable insights and rigorous scholarly work that are essential for researchers, professionals, and students seeking to deepen their understanding of psychological practices and theories. Located in Göttingen, Germany, the journal maintains its relevance by converging topics from various periods, ensuring a comprehensive review of evolving methodologies and psychosocial interventions from 1996 to 2024.

Expert Review of Clinical Pharmacology, published by TAYLOR & FRANCIS LTD, is a leading peer-reviewed journal dedicated to the field of clinical pharmacology, with a strong focus on the development and application of pharmacological therapies in patient care. Boasting an impressive impact, the journal ranks in the first quartile across multiple categories including Medicine (miscellaneous), Pharmacology (medical), and Pharmacology, Toxicology and Pharmaceutics (miscellaneous), reflecting its influential position within the scientific community. With a Scopus ranking of #6 in General Pharmacology, Toxicology and Pharmaceutics, the journal also achieves a commendable 93rd percentile, further emphasizing its importance as a resource for researchers and clinicians alike. As it continues to publish innovative reviews and research articles from 2008 until 2024, the Expert Review of Clinical Pharmacology plays an essential role in advancing knowledge, improving clinical practice, and fostering collaboration among experts in pharmacology, thereby driving forward the field's evolution towards better patient outcomes.